Organon/Medarex Expand UltiMab Antibody Agreement To Focus On Novel Target
This article was originally published in The Pink Sheet Daily
Executive Summary
Firms will codevelop Medarex-identified target, interim CEO Lerner tells “The Pink Sheet” DAILY.